2,641
Views
60
CrossRef citations to date
0
Altmetric
Brief Report

Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells

, , , ORCID Icon, , , , , , & show all
Article: e1424672 | Received 22 Sep 2017, Accepted 03 Jan 2018, Published online: 15 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

M. Merle, D. Fischbacher, A. Liepert, C. Grabrucker, T. Kroell, A. Kremser, J. Dreyssig, M. Freudenreich, F. Schuster, A. Borkhardt, D. Kraemer, C.-H. Koehne, H. J. Kolb, C. Schmid & H. M. Schmetzer. (2020) Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease. Immunological Investigations 49:4, pages 365-385.
Read now
Mano Nakamura, Heather J. Bax, Daniele Scotto, Elmira Amiri Souri, Sam Sollie, Robert J. Harris, Niklas Hammar, Goran Walldius, Anna Winship, Sharmistha Ghosh, Ana Montes, James F. Spicer, Mieke Van Hemelrijck, Debra H. Josephs, Katie E. Lacy, Sophia Tsoka & Sophia N. Karagiannis. (2019) Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma. OncoImmunology 8:6.
Read now

Articles from other publishers (58)

Salar Farokhi Boroujeni, Galaxia Rodriguez, Kristianne Galpin, Edward Yakubovich, Humaira Murshed, Dalia Ibrahim, Sara Asif & Barbara C. Vanderhyden. (2023) BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy. Journal of Ovarian Research 16:1.
Crossref
Yan-Ruide Li, Christopher J. Ochoa, Yichen Zhu, Adam Kramer, Matthew Wilson, Ying Fang, Yuning Chen, Tanya Singh, Gabriella Di Bernardo, Enbo Zhu, Derek Lee, Neda A. Moatamed, Joanne Bando, Jin J. Zhou, Sanaz Memarzadeh & Lili Yang. (2023) Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design. iScience 26:10, pages 107952.
Crossref
Luiza Côrtes, Tatiane Ramos Basso, Rolando André Rios Villacis, Jeferson dos Santos Souza, Mads Malik Aagaard Jørgensen, Maria Isabel Achatz & Silvia Regina Rogatto. (2023) Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary Breast and Colorectal Cancer Patients. Genes 14:8, pages 1580.
Crossref
Xinquan Yang, Toshiki Yabe-Wada, Jia Han, Fumiji Saito, Chie Ogasawara, Sohsuke Yamada & Nobuyuki Onai. (2023) PCBP1 acts as a regulator of CCL2 expression in macrophages to induce recruitment of monocyte-derived macrophages into the inflamed colon. International Immunology 35:6, pages 287-299.
Crossref
Jingchun Liu, Xiaoyi Zhang, Haoyu Wang, Xiaohu Zuo & Li Hong. (2023) Comprehensive Analysis of Purine-Metabolism-Related Gene Signature for Predicting Ovarian Cancer Prognosis, Immune Landscape, and Potential Treatment Options. Journal of Personalized Medicine 13:5, pages 776.
Crossref
Mara P. Steinkamp, Irina Lagutina, Kathryn J. Brayer, Fred Schultz, Danielle Burke, Vernon S. Pankratz, Sarah F. Adams, Laurie G. Hudson, Scott A. Ness & Angela Wandinger-Ness. (2023) Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity. Cancer Research Communications 3:2, pages 309-324.
Crossref
Selin Oncul & Min Soon Cho. (2023) Interactions between Platelets and Tumor Microenvironment Components in Ovarian Cancer and Their Implications for Treatment and Clinical Outcomes. Cancers 15:4, pages 1282.
Crossref
Shuangshuang Mei, Xing Chen, Kai Wang & Yuxin Chen. (2023) Tumor microenvironment in ovarian cancer peritoneal metastasis. Cancer Cell International 23:1.
Crossref
Phei Er Saw & Erwei Song. 2023. Tumor Ecosystem. Tumor Ecosystem 443 468 .
Noha Mousaad Elemam & Azzam A. Maghazachi. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 30 .
Xiaodi Gong & Xiaojun Liu. (2022) In-depth analysis of the expression and functions of signal transducers and activators of transcription in human ovarian cancer. Frontiers in Oncology 12.
Crossref
Diana Luísa Almeida-Nunes, Ana Mendes-Frias, Ricardo Silvestre, Ricardo Jorge Dinis-Oliveira & Sara Ricardo. (2022) Immune Tumor Microenvironment in Ovarian Cancer Ascites. International Journal of Molecular Sciences 23:18, pages 10692.
Crossref
Mohamad K. Hammoud, Raimund Dietze, Jelena Pesek, Florian Finkernagel, Annika Unger, Tim Bieringer, Andrea Nist, Thorsten Stiewe, Aditya M. Bhagwat, Wolfgang Andreas Nockher, Silke Reinartz, Sabine Müller‐Brüsselbach, Johannes Graumann & Rolf Müller. (2022) Arachidonic acid, a clinically adverse mediator in the ovarian cancer microenvironment, impairs JAK‐STAT signaling in macrophages by perturbing lipid raft structures. Molecular Oncology 16:17, pages 3146-3166.
Crossref
Lin Liu, Yangmei Chen, Jiayi Chen, Yuzhou Xue, Tingqiao Chen, Yuxin Li, Xinyi Shao & Jin Chen. (2022) Association between frontal fibrosing Alopecia and Rosacea: Results from clinical observational studies and gene expression profiles. Frontiers in Immunology 13.
Crossref
Jie Zhang, Tianhui He, Zhongnan Yin, Chunliang Shang, Lixiang Xue & Hongyan Guo. (2022) Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer. Frontiers in Oncology 12.
Crossref
Jie Fu & Xiaohua Lei. (2022) Identification of the Immune Subtype of Hepatocellular Carcinoma for the Prediction of Disease-Free Survival Time and Prevention of Recurrence by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data. Frontiers in Immunology 13.
Crossref
Militsa Rakina, Anna Kazakova, Alisa Villert, Larisa Kolomiets & Irina Larionova. (2022) Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components. International Journal of Molecular Sciences 23:11, pages 6215.
Crossref
Kathryn E. Cole, Quan P. Ly, Michael A. Hollingsworth, Jesse L. Cox, Kurt W. Fisher, James C. Padussis, Jason M. Foster, Luciano M. Vargas & James E. Talmadge. (2022) Splenic and PB immune recovery in neoadjuvant treated gastrointestinal cancer patients. International Immunopharmacology 106, pages 108628.
Crossref
Hideki Iwahashi, Morikazu Miyamoto, Tsubasa Ito, Jin Suminokura, Taira Hada, Hiroki Ishibashi, Soichiro Kakimoto, Hiroko Matsuura, Rie Suzuki, Shinya Minabe, Susumu Matsukuma, Hitoshi Tsuda & Masashi Takano. (2022) Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma. Cancer Medicine 11:10, pages 2085-2095.
Crossref
Zhenyi Xu, Jiali Song, Lei Cao, Zhiwei Rong, Wenjie Zhang, Jia He, Kang Li & Yan Hou. (2022) Improving ovarian cancer treatment decision using a novel risk predictive tool. Aging 14:8, pages 3464-3483.
Crossref
Nicole James, Ashley Valenzuela, Jenna Emerson, Morgan Woodman, Katherine Miller, Virginia Hovanesian, Joyce Ou & Jennifer Ribeiro. (2022) Intratumoral expression analysis reveals that OX40 and TIM‑3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancer. Oncology Letters 23:6.
Crossref
Andrew J. Wilson, Vijayalaxmi G Gupta, Qi Liu, Fiona Yull, Marta A. Crispens & Dineo Khabele. (2022) Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer. Neoplasia 24:2, pages 63-75.
Crossref
Hideyuki Takahashi, Koichi Sakakura, Shota Ida, Reika Kawabata‐Iwakawa, Toshiyuki Matsuyama, Hiroe Tada, Ikko Mito & Kazuaki Chikamatsu. (2021) Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma. Cancer Science 113:1, pages 53-64.
Crossref
Sanjay Rathod. 2022. Cellular Immunity in the Peritoneum. Cellular Immunity in the Peritoneum 15 41 .
Nathan Karin. (2021) Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?. Cancers 13:24, pages 6317.
Crossref
Xiaoyu Sun, Shan Li, Xuemei Lv, Yuanyuan Yan, Minjie Wei, Miao He & Xiaobin Wang. (2021) Immune-Related Long Non-coding RNA Constructs a Prognostic Signature of Ovarian Cancer. Biological Procedures Online 23:1.
Crossref
Gang Shi, Pengyi Shi, Yan Yu, Jia Xu, Jinhu Ma, Yong Zhang, Zhexu Dong, Lanlin Shen, Lei Dai, Lin Cheng, Ping Cheng & Hongxin Deng. (2021) Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment. Molecular Therapy - Oncolytics 23, pages 488-500.
Crossref
Qijie Zhao, Rawiwan Wongpoomchai, Arpamas Chariyakornkul, Zhangang Xiao & Chalermchai Pilapong. (2021) Identification of Gene-Set Signature in Early-Stage Hepatocellular Carcinoma and Relevant Immune Characteristics. Frontiers in Oncology 11.
Crossref
Jitka Fucikova, An Coosemans, Sandra Orsulic, David Cibula, Ignace Vergote, Lorenzo Galluzzi & Radek Spisek. (2021) Immunological configuration of ovarian carcinoma: features and impact on disease outcome. Journal for ImmunoTherapy of Cancer 9:10, pages e002873.
Crossref
Liang Mao, Yao Xiao, Qi-Chao Yang, Shao-Chen Yang, Lei-Lei Yang & Zhi-Jun Sun. (2021) TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells. Oral Oncology 121, pages 105472.
Crossref
Yuan-ke Liang, Ze-kun- Deng, Mu-tong Chen, Si-qi Qiu, Ying-sheng Xiao, Yu-zhu Qi, Qin Xie, Zheng-hao Wang, Shi-cheng Jia, De Zeng & Hao-yu Lin. (2021) CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer. Frontiers in Oncology 11.
Crossref
Jing Jin, Yi Li, Tobias Achu Muluh, Liangke Zhi & Qijie Zhao. (2021) Identification of CXCL10-Relevant Tumor Microenvironment Characterization and Clinical Outcome in Ovarian Cancer. Frontiers in Genetics 12.
Crossref
Quentin Klopfenstein, Valentin Derangère, Laurent Arnould, Marion Thibaudin, Emeric Limagne, Francois Ghiringhelli, Caroline Truntzer & Sylvain Ladoire. (2021) Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer. Journal for ImmunoTherapy of Cancer 9:6, pages e002036.
Crossref
Moshit Lindzen, Soma Ghosh, Ashish Noronha, Diana Drago, Nishanth Belugali Nataraj, Orith Leitner, Silvia Carvalho, Einav Zmora, Stav Sapoznik, Keren Bahar Shany, Keren Levanon, Dan Aderka, Belinda Sánchez Ramírez, Maik Dahlhoff, Iain McNeish & Yosef Yarden. (2021) Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53. Oncogene 40:21, pages 3665-3679.
Crossref
Aleksandra J. Ozga, Melvyn T. Chow & Andrew D. Luster. (2021) Chemokines and the immune response to cancer. Immunity 54:5, pages 859-874.
Crossref
Mingyong Liu, Aaron Silva-Sanchez, Troy D Randall & Selene Meza-Perez. (2021) Specialized immune responses in the peritoneal cavity and omentum. Journal of Leukocyte Biology 109:4, pages 717-729.
Crossref
Dong-feng Li, Aisikeer Tulahong, Md. Nazim Uddin, Huan Zhao & Hua Zhang. (2021) Meta-analysis identifying epithelial-derived transcriptomes predicts poor clinical outcome and immune infiltrations in ovarian cancer. Quantitative Finance and Economics 18:5, pages 6527-6551.
Crossref
Maureen L. Drakes & Patrick J. Stiff. 2021. Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies. Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies 33 54 .
Alyssa A. Hoover, Demetra H. Hufnagel, Whitney Harris, Kennady Bullock, Evan B. Glass, Esther Liu, Whitney Barham, Marta A. Crispens, Dineo Khabele, Todd D. Giorgio, Andrew J. Wilson & Fiona E. Yull. (2020) Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer. BMC Cancer 20:1.
Crossref
Sabine Mueller, Jared M. Taitt, Javier E. Villanueva-Meyer, Erin R. Bonner, Takahide Nejo, Rishi R. Lulla, Stewart Goldman, Anu Banerjee, Susan N. Chi, Nicholas S. Whipple, John R. Crawford, Karen Gauvain, Kellie J. Nazemi, Payal B. Watchmaker, Neil D. Almeida, Kaori Okada, Andres M. Salazar, Ryan D. Gilbert, Javad Nazarian, Annette M. Molinaro, Lisa H. Butterfield, Michael D. Prados & Hideho Okada. (2020) Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. Journal of Clinical Investigation 130:12, pages 6325-6337.
Crossref
Nupur Biswas & Saikat Chakrabarti. (2020) Artificial Intelligence (AI)-Based Systems Biology Approaches in Multi-Omics Data Analysis of Cancer. Frontiers in Oncology 10.
Crossref
Jessica Vazquez, Melina Chavarria, Gladys E. Lopez, Mildred A. Felder, Arvinder Kapur, Antonio Romo Chavez, Nathan Karst, Lisa Barroilhet, Manish S. Patankar & Aleksandar K. Stanic. (2020) Identification of unique clusters of T, dendritic, and innate lymphoid cells in the peritoneal fluid of ovarian cancer patients. American Journal of Reproductive Immunology 84:3.
Crossref
Henrique Spaulonci Silveira, Luiz Antonio Lupi, Graziela Gorete Romagnoli, Ramon Kaneno, Iseu da Silva Nunes, Wagner José Fávaro & Luiz Gustavo de Almeida Chuffa. (2020) P-MAPA activates TLR2 and TLR4 signaling while its combination with IL-12 stimulates CD4+ and CD8+ effector T cells in ovarian cancer. Life Sciences 254, pages 117786.
Crossref
Caroline Elizabeth Ford, Bonnita Werner, Neville Frederick Hacker & Kristina Warton. (2020) The untapped potential of ascites in ovarian cancer research and treatment. British Journal of Cancer 123:1, pages 9-16.
Crossref
Yanwei Zhang, Beibei Sun, Minjuan Hu, Yuqing Lou, Jun Lu, Xueyan Zhang, Huimin Wang, Jialin Qian, Tianqing Chu & Baohui Han. (2020) CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients. Frontiers in Oncology 10.
Crossref
Mélissa Prat, Augustin Le Naour, Kimberley Coulson, Fanny Lemée, Hélène Leray, Godefroy Jacquemin, Mouna Chirine Rahabi, Léa Lemaitre, Hélène Authier, Gwenaël Ferron, Jean-Marc Barret, Alejandra Martinez, Maha Ayyoub, Jean-Pierre Delord, Laurence Gladieff, Isabelle Tabah-Fisch, Jean-François Prost, Bettina Couderc & Agnès Coste. (2020) Circulating CD14 high CD16 low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression . Journal for ImmunoTherapy of Cancer 8:1, pages e000472.
Crossref
Hans-Heinrich Oberg, Lisa Janitschke, Vjola Sulaj, Jörg Weimer, Daniel Gonnermann, Nina Hedemann, Norbert Arnold, Dieter Kabelitz, Matthias Peipp, Dirk Bauerschlag & Daniela Wesch. (2020) Bispecific antibodies enhance tumor-infiltrating T cell cytotoxicity against autologous HER-2-expressing high-grade ovarian tumors. Journal of Leukocyte Biology 107:6, pages 1081-1095.
Crossref
Wendell D. Jones, Chad M. Michener, Charles Biscotti, Iona Braicu, Jalid Sehouli, Mahrukh K. Ganapathi & Ram N. Ganapathi. (2020) RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers. Cancers 12:3, pages 620.
Crossref
Eleonora Timperi, Elena Vissio, Caterina Marchiò & Emanuela Romano. 2020. Tumor Microenvironment. Tumor Microenvironment 215 249 .
Krishna Sriram, Shu Z. Wiley, Kevin Moyung, Matthew W. Gorr, Cristina Salmerón, Jordin Marucut, Randall P. French, Andrew M. Lowy & Paul A. Insel. (2019) Detection and Quantification of GPCR mRNA: An Assessment and Implications of Data from High-Content Methods. ACS Omega 4:16, pages 17048-17059.
Crossref
Jia He, Yinjing Song, Gaopeng Li, Peng Xiao, Yang Liu, Yue Xue, Qian Cao, Xintao Tu, Ting Pan, Zhinong Jiang, Xuetao Cao, Lihua Lai & Qingqing Wang. (2019) Fbxw7 increases CCL2/7 in CX3CR1hi macrophages to promote intestinal inflammation. Journal of Clinical Investigation 129:9, pages 3877-3893.
Crossref
Marina Martinez & Edmund Kyung Moon. (2019) CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment. Frontiers in Immunology 10.
Crossref
Silke Reinartz, Sonja Lieber, Jelena Pesek, Dominique T. Brandt, Alina Asafova, Florian Finkernagel, Bernard Watzer, Wolfgang Andreas Nockher, Andrea Nist, Thorsten Stiewe, Julia M. Jansen, Uwe Wagner, Anne Konzer, Johannes Graumann, Robert Grosse, Thomas Worzfeld, Sabine Müller‐Brüsselbach & Rolf Müller. (2018) Cell type‐selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment. Molecular Oncology 13:2, pages 185-201.
Crossref
Dounia Chraa, Asmaa Naim, Daniel Olive & Abdallah Badou. (2019) T lymphocyte subsets in cancer immunity: Friends or foes. Journal of Leukocyte Biology 105:2, pages 243-255.
Crossref
Christina Wefers, Tjitske Duiveman-de Boer, Refika Yigit, Petra L. M. Zusterzeel, Anne M. van Altena, Leon F. A. G. Massuger & I. Jolanda M. De Vries. (2019) Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites. Frontiers in Immunology 9.
Crossref
James Scurry, Belinda van Zyl, Damien Gulliver, Geoffrey Otton, Kenneth Jaaback, Janine Lombard, Ricardo E. Vilain & Nikola A. Bowden. (2018) Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer. Gynecologic Oncology 151:2, pages 306-310.
Crossref
Janneke S. Hoogstad-van Evert, Ralph J. Maas, Jolien van der Meer, Jeannette Cany, Sophieke van der Steen, Joop H. Jansen, Jeffrey S. Miller, Ruud Bekkers, Willemijn Hobo, Leon Massuger & Harry Dolstra. (2018) Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients. Oncotarget 9:78, pages 34810-34820.
Crossref
Curtis McCloskey, Galaxia Rodriguez, Kristianne Galpin & Barbara Vanderhyden. (2018) Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics. Cancers 10:8, pages 244.
Crossref